Tmunity Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 27

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.3B

  • Investors
  • 2

Tmunity General Information

Description

Operator of a next-generation immunotherapies development company intended to deliver cell immunotherapy to patients to treat a wide range of disease indications. The company specializes in developing novel cell receptors and engineered T-cell platforms that exhibit control over T-cell activation and direction as well as proprietary technologies to activate, expand, and genetically engineer T-cells from peripheral blood, cord blood, and tumors, thereby enabling physicians to progress in the treatment of oncology, infectious diseases, and autoimmune diseases.

Contact Information

Website
www.tmunity.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3020 Market Street
  • Suite 535
  • Philadelphia, PA 19104
  • United States
+1 (215)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 3020 Market Street
  • Suite 535
  • Philadelphia, PA 19104
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tmunity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 22-Feb-2023 $1.3B Completed Generating Revenue
4. Early Stage VC (Series B) 30-Oct-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Apr-2018 Completed Generating Revenue
2. Seed Round 12-Jan-2016 $10M $10M Completed Generating Revenue
1. University Spin-Out 01-Jan-2009 Completed Startup
To view Tmunity’s complete valuation and funding history, request access »

Tmunity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
Seed 1,968,007 $0.000100 6% $4.41 $4.41 1x $4.41 4.78%
To view Tmunity’s complete cap table history, request access »

Tmunity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a next-generation immunotherapies development company intended to deliver cell immunotherapy to patients to
Biotechnology
Philadelphia, PA
27 As of 2023

Cambridge, MA
 

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tmunity Competitors (31)

One of Tmunity’s 31 competitors is Marengo Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Marengo Therapeutics Venture Capital-Backed Cambridge, MA
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
Centrose Venture Capital-Backed Madison, WI
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Lisata Therapeutics Corporation Basking Ridge, NJ
You’re viewing 5 of 31 competitors. Get the full list »

Tmunity Patents

Tmunity Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240123068-A1 Cd19 binders, car-t constructs comprising the same, and methods of using the same Pending 18-Oct-2022
US-20230190809-A1 Alternative generation of allogeneic human t cells Pending 10-Sep-2021
WO-2023039041-A1 Alternative generation of allogeneic human t cells Inactive 10-Sep-2021
WO-2023009412-A1 Dnvsig3 and dnvsig8 receptors and methods of using the same Inactive 26-Jul-2021
AU-2021332334-A1 Vector-free process for manufacture of engineered immune cells Pending 27-Aug-2020 C12N5/0636
To view Tmunity’s complete patent history, request access »

Tmunity Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tmunity Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACS BrightEdge Corporate Venture Capital Minority
Andreessen Horowitz Venture Capital Minority
Cultural Leadership Fund Venture Capital Minority
Kleiner Perkins Venture Capital Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Tmunity FAQs

  • When was Tmunity founded?

    Tmunity was founded in 2009.

  • Where is Tmunity headquartered?

    Tmunity is headquartered in Philadelphia, PA.

  • What is the size of Tmunity?

    Tmunity has 27 total employees.

  • What industry is Tmunity in?

    Tmunity’s primary industry is Biotechnology.

  • Is Tmunity a private or public company?

    Tmunity is a Private company.

  • What is the current valuation of Tmunity?

    The current valuation of Tmunity is .

  • What is Tmunity’s current revenue?

    The current revenue for Tmunity is .

  • How much funding has Tmunity raised over time?

    Tmunity has raised $220M.

  • Who are Tmunity’s investors?

    ACS BrightEdge, Andreessen Horowitz, Cultural Leadership Fund, Kleiner Perkins, and LAV (Lilly Asia Fund) are 5 of 12 investors who have invested in Tmunity.

  • Who are Tmunity’s competitors?

    Marengo Therapeutics, Cellaion, Centrose, Adaptimmune Therapeutics, and Lisata Therapeutics are some of the 31 competitors of Tmunity.

  • When was Tmunity acquired?

    Tmunity was acquired on 22-Feb-2023.

  • Who acquired Tmunity?

    Tmunity was acquired by Kite Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process